UB Paderborn / Katalog / Suche / in CDI

Microbiological controls of aseptic handling in Dutch hospital pharmacies: Results, limits, and methods for assessing

European journal of pharmaceutical sciences, 2022-08, Vol.175, p.106228-106228, Article 106228

2022

Link zum Volltext

Verfügbarkeit prüfen

3D printed furosemide and sildenafil tablets: Innovative production and quality control

International journal of pharmaceutics, 2021-06, Vol.603, p.120694, Article 120694

2021

Link zum Volltext

Verfügbarkeit prüfen

Development and Bioequivalence of 3D‐Printed Medication at the Point‐of‐Care: Bridging the Gap Toward Personalized Medicine

Clinical pharmacology and therapeutics, 2023-05, Vol.113 (5), p.1125-1131

2023

Link zum Volltext

Verfügbarkeit prüfen

Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part C: applying risk assessment and risk control in practice

European journal of hospital pharmacy. Science and practice, 2023-05, Vol.30 (3), p.160-166

2023

Link zum Volltext

Verfügbarkeit prüfen

Improving the aseptic transfer procedures in hospital pharmacies. Part B: evaluation of disinfection methods for materials with a non-sterile surface

European journal of hospital pharmacy. Science and practice, 2021-09, Vol.28 (5), p.271-275

2021

Link zum Volltext

Verfügbarkeit prüfen

Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part B: risk control

European journal of hospital pharmacy. Science and practice, 2021-11, Vol.28 (6), p.325-330

2021

Link zum Volltext

Verfügbarkeit prüfen

Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part A: risk assessment

European journal of hospital pharmacy. Science and practice, 2022-05, Vol.29 (3), p.151-156

2022

Link zum Volltext

Verfügbarkeit prüfen

Preparation has a future

European journal of hospital pharmacy. Science and practice, 2019-11, Vol.26 (6), p.300-300

Le Brun, Paul P H

2019

Link zum Volltext

Verfügbarkeit prüfen

Improving the aseptic transfer procedures in hospital pharmacies part A: methods for the determination of the surface bioburden on ampoules and vials

European journal of hospital pharmacy. Science and practice, 2021-01, Vol.28 (1), p.38-41

2021

Link zum Volltext

Verfügbarkeit prüfen

Improving the aseptic transfer procedures in hospital pharmacies part C: evaluation and redesign of the transfer process

European journal of hospital pharmacy. Science and practice, 2022-01, Vol.29 (1), p.12-17

2022

Link zum Volltext

Verfügbarkeit prüfen

Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety

Pharmacoepidemiology and drug safety, 2018-01, Vol.27 (1), p.3-8

2018

Link zum Volltext

Verfügbarkeit prüfen

The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis

Journal of cystic fibrosis, 2015-11, Vol.14 (6), p.748-754

2015

Link zum Volltext

Verfügbarkeit prüfen

Letter to the editor

Osteoarthritis and cartilage, 1997-07, Vol.5 (4), p.289-291

Brun, P.H.

1997

Link zum Volltext

Verfügbarkeit prüfen

Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study

Journal of cystic fibrosis, 2007-07, Vol.6 (4), p.284-292

2007

Link zum Volltext

Verfügbarkeit prüfen

Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer ®) for high powder doses

European journal of pharmaceutical sciences, 2006-06, Vol.28 (3), p.171-178

2006

Link zum Volltext

Verfügbarkeit prüfen

Aseptic preparation of parenteral medicinal products in healthcare establishments in Europe

European journal of hospital pharmacy. Science and practice, 2016-01, Vol.23 (1), p.50-53

2016

Link zum Volltext

Verfügbarkeit prüfen

Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study

International journal of pharmaceutics, 2007-04, Vol.335 (1-2), p.41-45

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study

Journal of cystic fibrosis, 2004-03, Vol.3 (1), p.23-28

2004

Link zum Volltext

Verfügbarkeit prüfen

Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2: Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients

European journal of pharmaceutics and biopharmaceutics, 2002-07, Vol.54 (1), p.25-32

2002

Link zum Volltext

Verfügbarkeit prüfen

Aerosolization of tobramycin (TOBI) with the PARI LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressor

Journal of aerosol medicine and pulmonary drug delivery, 2008-09, Vol.21 (3), p.269

2008

Link zum Volltext

Verfügbarkeit prüfen

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle

European journal of pharmaceutics and biopharmaceutics, 2002-07, Vol.54 (1), p.17-24

2002

Link zum Volltext

Verfügbarkeit prüfen

High-performance liquid chromatographic method for the determination of colistin in serum

Therapeutic drug monitoring, 2000-10, Vol.22 (5), p.589-593

2000

Link zum Volltext

Verfügbarkeit prüfen

Drug output of unvented jet nebulizers as a function of time

International journal of pharmaceutics, 2003-05, Vol.257 (1), p.33-39

2003

Link zum Volltext

Verfügbarkeit prüfen

Inhalation of tobramycin in cystic fibrosis: Part 2: Optimization of the tobramycin solution for a jet and an ultrasonic nebulizer

International journal of pharmaceutics, 1999-11, Vol.189 (2), p.215-225

1999

Link zum Volltext

Verfügbarkeit prüfen

Can tobramycin inhalation be improved with a jet nebulizer?

Therapeutic drug monitoring, 1999-12, Vol.21 (6), p.618-624

1999

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Microbiological controls of aseptic handling in Dutch hospital pharmacies: Results, limits, and methods for assessing

3D printed furosemide and sildenafil tablets: Innovative production and quality control

Development and Bioequivalence of 3D‐Printed Medication at the Point‐of‐Care: Bridging the Gap Toward Personalized Medicine

Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part C: applying risk assessment and risk control in practice

Improving the aseptic transfer procedures in hospital pharmacies. Part B: evaluation of disinfection methods for materials with a non-sterile surface

Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part B: risk control

Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part A: risk assessment

Preparation has a future

Improving the aseptic transfer procedures in hospital pharmacies part A: methods for the determination of the surface bioburden on ampoules and vials

Improving the aseptic transfer procedures in hospital pharmacies part C: evaluation and redesign of the transfer process

Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety

The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis

Letter to the editor

Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study

Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer ®) for high powder doses

Aseptic preparation of parenteral medicinal products in healthcare establishments in Europe

Dry powder inhalation of colistin sulphomethate in healthy volunteers: A pilot study

Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study

Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2: Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients

Aerosolization of tobramycin (TOBI) with the PARI LC PLUS reusable nebulizer: which compressor to use? Comparison of the CR60 to the PortaNeb compressor

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle

High-performance liquid chromatographic method for the determination of colistin in serum

Drug output of unvented jet nebulizers as a function of time

Inhalation of tobramycin in cystic fibrosis: Part 2: Optimization of the tobramycin solution for a jet and an ultrasonic nebulizer

Can tobramycin inhalation be improved with a jet nebulizer?

Suchergebnisse filtern